Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. sophomore Good
|
|
New words:
AstraZeneca, attrition, budesonide, classification, composition, convenient, converted, CR, derecognition, documentation, downsizing, Dr, employment, enterprise, ethyl, FAS, FIN, flat, formoterol, furniture, IIb, long, morale, Oxley, PDUFA, Phenome, pilot, Pittsburgh, powered, presence, proceed, published, pyruvate, rebuild, room, signal, stimuli, Symbicort, threshold, tolerability, undesirable, UPitt, urgent, User, withholding, ZYLFLO
Removed:
animal, anticipation, avoid, aware, built, cell, cholinergic, circulating, commencing, conform, declared, diminished, dismantle, efficient, enhance, enhancement, equaled, financed, flow, forecasting, formed, generated, growth, improve, inhibit, joined, Likewise, member, neutralize, nicotinic, performing, placebo, procure, receptor, reclassified, reclassify, redeploy, relation, restate, revise, sNDA, stability, targeting, unilateral, unrecoverable
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.2 EX-10.2 - Warrant Agreement Dated October 31, 2006 by and Between Registrant and Mellon Investor Services
- 31 EX-31 - Sec 302 Certification of Principal Executive Officer and Principal Financial Officer
- 32 EX-32 - Sec 906 Certification of Principal Executive Officer and Principal Financial Officer
Related press release
CRTX similar filings
External links